These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32236166)

  • 21. Epidemiology of La Crosse Virus Emergence, Appalachia Region, United States.
    Bewick S; Agusto F; Calabrese JM; Muturi EJ; Fagan WF
    Emerg Infect Dis; 2016 Nov; 22(11):1921-1929. PubMed ID: 27767009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.
    Haddow AD; Bixler D; Odoi A
    BMC Infect Dis; 2011 Jan; 11():29. PubMed ID: 21269495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cemeteries are effective sites for monitoring la crosse virus (LACv) and these environments may play a role in LACv infection.
    Trout Fryxell RT; Freyman K; Ulloa A; Hendricks B; Paulsen D; Odoi A; Moncayo A
    PLoS One; 2015; 10(4):e0122895. PubMed ID: 25860584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.
    Ojha D; Winkler CW; Leung JM; Woods TA; Chen CZ; Nair V; Taylor K; Yeh CD; Tawa GJ; Larson CL; Zheng W; Haigh CL; Peterson KE
    Nat Microbiol; 2021 Nov; 6(11):1398-1409. PubMed ID: 34675384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007.
    Haddow AD; Odoi A
    PLoS One; 2009 Jul; 4(7):e6145. PubMed ID: 19582158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity.
    Boutzoukas AE; Freedman DA; Koterba C; Hunt GW; Mack K; Cass J; Yildiz VO; de Los Reyes E; Twanow J; Chung MG; Ouellette CP
    Clin Infect Dis; 2023 Feb; 76(3):e1114-e1122. PubMed ID: 35607778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. La Crosse virus spread within the mosquito population in Knox County, TN.
    Cook C; Blesi A; Brozak S; Lenhart S; Reed H; Urquhart C; Moncayo A; Trout Fryxell R
    PLoS One; 2021; 16(4):e0249811. PubMed ID: 33861763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. La Crosse Virus in Aedes japonicus japonicus mosquitoes in the Appalachian Region, United States.
    Harris MC; Dotseth EJ; Jackson BT; Zink SD; Marek PE; Kramer LD; Paulson SL; Hawley DM
    Emerg Infect Dis; 2015 Apr; 21(4):646-9. PubMed ID: 25811131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. La Crosse virus encephalitis in children.
    Ouellette CP
    Curr Opin Infect Dis; 2024 Oct; 37(5):419-424. PubMed ID: 39079177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Status of La Crosse Virus in North America and Potential for Future Spread.
    Goldman T; Hamer DH
    Am J Trop Med Hyg; 2024 May; 110(5):850-855. PubMed ID: 38531108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impacts of climate, land use, and biological invasion on the ecology of immature Aedes mosquitoes: implications for La Crosse emergence.
    Leisnham PT; Juliano SA
    Ecohealth; 2012 Jun; 9(2):217-28. PubMed ID: 22692799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The La Crosse virus class II fusion glycoprotein
    Thannickal SA; Spector SN; Stapleford KA
    J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible congenital infection with La Crosse encephalitis virus--West Virginia, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):4-7. PubMed ID: 19145220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. La Crosse encephalitis presenting like herpes simplex encephalitis in an immunocompromised adult.
    Wurtz R; Paleologos N
    Clin Infect Dis; 2000 Oct; 31(4):1113-4. PubMed ID: 11049801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
    Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
    Virol J; 2007 May; 4():41. PubMed ID: 17488515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
    Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
    J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical comparisons of La Crosse encephalitis and enteroviral central nervous system infections in a pediatric population: 2001 surveillance in East Tennessee.
    Hardin SG; Erwin PC; Patterson L; New D; Graber C; Halford SK
    Am J Infect Control; 2003 Dec; 31(8):508-10. PubMed ID: 14647115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of Acute Flaccid Paralysis Reported with La Crosse Virus Infection, Ohio, USA, 2008-2014.
    Hennessey MJ; Pastula DM; Machesky K; Fischer M; Lindsey NP; DiOrio M; Staples JE; de Fijter S
    Emerg Infect Dis; 2017 Dec; 23(12):2075-2077. PubMed ID: 29148398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic and social impacts of La Crosse encephalitis in western North Carolina.
    Utz JT; Apperson CS; MacCormack JN; Salyers M; Dietz EJ; McPherson JT
    Am J Trop Med Hyg; 2003 Nov; 69(5):509-18. PubMed ID: 14695088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
    Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
    J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.